Swiss National Bank raised its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH – Get Rating) by 13.9% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 339,000 shares of the company’s stock after buying an additional 41,300 shares during the quarter. Swiss National Bank owned about 0.19% of Option Care Health worth $9,421,000 as of its most recent SEC filing.
A number of other large investors also recently modified their holdings of the business. State Street Corp lifted its holdings in shares of Option Care Health by 3.0% during the first quarter. State Street Corp now owns 4,539,810 shares of the company’s stock worth $129,657,000 after buying an additional 133,504 shares during the last quarter. Bellevue Group AG raised its stake in shares of Option Care Health by 10.6% in the first quarter. Bellevue Group AG now owns 3,232,787 shares of the company’s stock valued at $92,328,000 after purchasing an additional 308,744 shares in the last quarter. Loomis Sayles & Co. L P raised its stake in shares of Option Care Health by 65.1% in the first quarter. Loomis Sayles & Co. L P now owns 2,676,475 shares of the company’s stock valued at $76,440,000 after purchasing an additional 1,055,722 shares in the last quarter. Goldman Sachs Group Inc. raised its stake in shares of Option Care Health by 44.8% in the first quarter. Goldman Sachs Group Inc. now owns 2,246,243 shares of the company’s stock valued at $64,153,000 after purchasing an additional 694,540 shares in the last quarter. Finally, JPMorgan Chase & Co. raised its stake in shares of Option Care Health by 8.2% in the first quarter. JPMorgan Chase & Co. now owns 2,200,320 shares of the company’s stock valued at $62,840,000 after purchasing an additional 167,399 shares in the last quarter. 92.58% of the stock is currently owned by institutional investors and hedge funds.
Option Care Health Stock Performance
Shares of NASDAQ:OPCH opened at $28.69 on Monday. The business’s fifty day moving average price is $31.84 and its two-hundred day moving average price is $30.89. Option Care Health, Inc. has a fifty-two week low of $21.32 and a fifty-two week high of $35.87. The stock has a market capitalization of $5.22 billion, a price-to-earnings ratio of 29.28, a price-to-earnings-growth ratio of 2.68 and a beta of 1.21. The company has a debt-to-equity ratio of 0.79, a current ratio of 1.62 and a quick ratio of 1.22.
Analysts Set New Price Targets
A number of research analysts recently commented on the company. Barrington Research upped their target price on Option Care Health from $37.00 to $38.00 and gave the company an “outperform” rating in a research note on Friday, October 28th. The Goldman Sachs Group upped their target price on Option Care Health from $31.00 to $40.00 and gave the company a “buy” rating in a research note on Monday, August 22nd. Finally, Lake Street Capital upped their target price on Option Care Health from $35.00 to $45.00 in a research note on Thursday, July 28th.
Insider Transactions at Option Care Health
In other news, Director R Carter Pate sold 1,928 shares of the stock in a transaction on Monday, October 3rd. The stock was sold at an average price of $31.97, for a total transaction of $61,638.16. Following the sale, the director now owns 95,530 shares in the company, valued at $3,054,094.10. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 0.22% of the company’s stock.
Option Care Health Company Profile
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
- Get a free copy of the StockNews.com research report on Option Care Health (OPCH)
- Is GameStop Stock Setting Up for Another Short Squeeze?
- Here’s Why SoFi Technologies Stock is Cheap at These Levels
- Warren Buffet Bought Taiwan Semiconductor Stock, Should You?
- MarketBeat: Week in Review 11/14 – 11/18
- Target’s Double Bottom Might Have Just Been Confirmed
Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.